http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2640447-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31f0b29ffcbf2734a08075e12e469031 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067 |
| filingDate | 2016-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4111c449c25f069fa9b94d4a7b63ac3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c50e5897bd105e2b196fa07f551f17d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d154700a7edacd86366e6528de8d37c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cdbed93924f48a7c929835e11cbd0df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be706e3740d233eed1723ba0f0896453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9adf07dfd7b1289fe9a1654cf8f2faad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52e9342c41d130cce17aa35bad9b7dbb |
| publicationDate | 2018-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2640447-C1 |
| titleOfInvention | Method of treatment of rosazea |
| abstract | FIELD: medicine. n SUBSTANCE: processing of abnormal focus of facial skin by laser equipment SP Dualis Spectro Nd: YAG by laser with 1064 nm wavelength is carried out, using a laser scanner headpiece S-11.40 j/cm 2 , frequency of 3Hz, pulse length 30-50 Ms. Wherein the number of treatments per procedure is from 1 to 3 times. Then immediately consistently injections of ozone-oxygen mixture, obtained on installation of "Medozons BM" in the concentration of 1300-1600 mcg/l is carried out both directly under the abnormal focus and on the entire face surface, maintaining the distance between injections 2.5 cm. At the same time, 6 procedures are performed at intervals of 2 times a week, then 3 procedures at an interval of 1 time per week and 3 procedures at an interval of 1 time per month, the course of treatment is repeated after 1.5-3 months. Method allows to lengthen the remission up to 24 months at I stage of erythematous-telangiectatic, at stage II papulopustular at 81.2% of patients and up to 14-18 months, at stage III pustular-nodulous form of disease at 58.2% of cases up to 12-16 months. n EFFECT: method has a higher therapeutic efficacy. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2790768-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2719644-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2734841-C1 |
| priorityDate | 2016-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.